Welcome to NCSH Sexual Health in the News. This weekly online digest was created to keep you up-to-date on sexual health topics currently trending in the media.The NCSH does not endorse specific content or research included in these articles.
In August, the FDA approved flibanserin, also known as Addyi, for premenopausal women diagnosed with sexual desire dysfunction. Here's how it works and why some are calling it a game changer.
Most women with low sexual desire won't rush to get the first prescription drug to boost female libido when it becomes available on Saturday, but they may have more options down the road.
Amidst all the debate about campus sexual assault, there are still questions about the scope of the problem. Two graduate students at Stanford suggest a way to better determine its prevalence.
As part of a "Sex on Campus" package, New York Magazine polled more than 700 college students around the country about the hookup and sex cultures on their campuses.
Intimate partner violence, or domestic violence, affects one in three women in the US, but among women who also have HIV/AIDS, this incidence climbs to one in two.
While Viagra is an FDA-approved drug to treat erectile dysfunction, there are also over-the-counter supplements for sexual enhancement that claim to be "all-natural" or "herbal," but are not approved by the FDA, and do not undergo safety testing.
Social Media Outreach
If you would like us to promote any of your resources or work through our social media channels, please forward it to [email protected].
